We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
-2.48%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$812B
AUM Growth
-$55.8B
Cap. Flow
-$18.8B
Cap. Flow %
-2.31%
Top 10 Hldgs %
32.22%
Holding
3,109
New
91
Increased
2,002
Reduced
738
Closed
70

Top Buys

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$3.81B
2
XYZ
Block Inc
XYZ
+$1.46B
3
ACN icon
Accenture
ACN
+$1.23B
4
GILD icon
Gilead Sciences
GILD
+$1.15B
5
VLO icon
Valero Energy
VLO
+$1.05B

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$4.61B
2
META icon
Meta Platforms (Facebook)
META
+$2.06B
3
TSLA icon
Tesla
TSLA
+$1.81B
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$1.72B
5
AMZN icon
Amazon
AMZN
+$1.59B

Sector Composition

Rank Sector Weight
1 Technology 30.44%
2 Healthcare 13.92%
3 Financials 12.3%
4 Consumer Discretionary 10.98%
5 Communication Services 9.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABBV icon
101
AbbVie
ABBV
$440B
$1.51B 0.19%
7,194,814
-2,999,412
-29% -$583M
SPGI icon
102
S&P Global
SPGI
$121B
$1.5B 0.18%
2,947,239
+614,809
+26% +$314M
NTRA icon
103
Natera
NTRA
$45.5B
$1.49B 0.18%
10,537,743
+3,795,315
+56% +$610M
PGR icon
104
Progressive
PGR
$121B
$1.49B 0.18%
5,260,857
-447,373
-8% -$117M
PH icon
105
Parker-Hannifin
PH
$135B
$1.49B 0.18%
2,443,104
+842,262
+53% +$551M
CPNG icon
106
Coupang
CPNG
$29.3B
$1.48B 0.18%
67,694,199
-7,992,449
-11% -$186M
EQR icon
107
Equity Residential
EQR
$24.2B
$1.48B 0.18%
20,711,588
+1,101,027
+6% +$77.8M
HIG icon
108
Hartford Financial Services
HIG
$37.7B
$1.47B 0.18%
11,906,057
-720,850
-6% -$82.6M
XYZ
109
Block Inc
XYZ
$47B
$1.46B 0.18%
26,921,934
+19,569,143
+266% +$1.46B
CME icon
110
CME Group
CME
$94.3B
$1.45B 0.18%
5,448,310
-2,832,475
-34% -$699M
TJX icon
111
TJX Companies
TJX
$169B
$1.44B 0.18%
11,853,004
-281,006
-2% -$34.1M
VLO icon
112
Valero Energy
VLO
$95.1B
$1.43B 0.18%
10,795,436
+7,931,018
+277% +$1.05B
FCX icon
113
Freeport-McMoran
FCX
$96.9B
$1.42B 0.18%
37,547,489
+5,661,958
+18% +$217M
SWK icon
114
Stanley Black & Decker
SWK
$15.5B
$1.42B 0.17%
18,456,384
+42,471
+0.2% +$3.58M
LULU icon
115
lululemon athletica
LULU
$13.7B
$1.42B 0.17%
5,010,908
+162,295
+3% +$59.5M
VRTX icon
116
Vertex Pharmaceuticals
VRTX
$133B
$1.41B 0.17%
2,917,227
+1,226,527
+73% +$572M
FTI icon
117
TechnipFMC
FTI
$29.5B
$1.41B 0.17%
44,495,926
-4,453,766
-9% -$134M
REGN icon
118
Regeneron Pharmaceuticals
REGN
$82.2B
$1.38B 0.17%
2,175,026
+89,579
+4% +$61.6M
PSA icon
119
Public Storage
PSA
$60.4B
$1.37B 0.17%
4,571,977
-1,339,666
-23% -$401M
WELL icon
120
Welltower
WELL
$166B
$1.37B 0.17%
8,923,852
+2,622,384
+42% +$374M
SO icon
121
Southern Company
SO
$106B
$1.37B 0.17%
14,866,776
-1,009,664
-6% -$87.4M
SBUX icon
122
Starbucks
SBUX
$124B
$1.36B 0.17%
13,902,707
-326,742
-2% -$33.8M
CEG icon
123
Constellation Energy
CEG
$98.7B
$1.36B 0.17%
6,728,596
-1,331,469
-17% -$357M
AZO icon
124
AutoZone
AZO
$49.7B
$1.33B 0.16%
349,317
+24,701
+8% +$85.2M
MS icon
125
Morgan Stanley
MS
$342B
$1.32B 0.16%
11,320,148
-2,792,360
-20% -$360M

Similar funds

T. Rowe Price Associates's Q1 2025 Portfolio in Review

As of Q1 2025, T. Rowe Price Associates held 3,109 positions worth $812B, down 6.4% from $867B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

T. Rowe Price Associates's Q1 2025 filing shows 91 new, 2,002 increased, 738 reduced and 70 closed positions. Its largest new stake was T. Rowe Price Value ETF: 8,943,567 shares worth $283M. The largest sale was NVIDIA, an estimated $4.61B.

By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 33% a quarter earlier, followed by Healthcare and Financials.

  • T. Rowe Price Associates's largest Q1 2025 buy was T. Rowe Price Value ETF: 8,943,567 shares worth $283M.
  • T. Rowe Price Associates added most to Broadcom in Q1 2025, an estimated $3.81B increase.
  • T. Rowe Price Associates's biggest Q1 2025 reduction was NVIDIA, cutting an estimated $4.61B.
  • T. Rowe Price Associates fully exited Summit Materials, Inc. Class A Common Stock in Q1 2025, selling an estimated $271M.
  • T. Rowe Price Associates's ten largest holdings make up 32% of its $812B portfolio in Q1 2025.
  • T. Rowe Price Associates opened 91 new positions and closed 70 in Q1 2025.
  • T. Rowe Price Associates's portfolio value fell 6.4% quarter-over-quarter to $812B.

Based on T. Rowe Price Associates's 13F filing for Q1 2025, filed 14 May 2025.